Germany Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking

Date: December 1, 2016
Pages: 50
Price:
US$ 1,000.00
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: G82039BA4C8EN
Leaflet:

Download PDF Leaflet

Germany Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
  • The report analyses Pharmaceuticals and Biotechnology Industry in Germany. It covers general statistics, including industry volumes by sales and income, and industry dynamics within the recent period. The description of industry structure by company is included as well, establishing extent of market concentration and evaluating companies’ market shares. Analysis includes detailed information about the internal and external factors that affect Pharmaceuticals and Biotechnology Industry in Germany.
  • The report provides detailed Pharmaceuticals and Biotechnology Industry comparative analysis with interrelated data on major companies. The areas under consideration are as follows:
    - company strategic position in the industry
    - profitability and margin analysis
    - assets turnover and credit ratios reviews
    - long-term solvency indicators
    - growth trends comparison
  • The report also presents company rankings by size, value, profit margin and growth history, thus giving a full picture of each company mentioned.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases. Annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of the industry.

RESEARCH METHODOLOGY

DISCLAIMER

1. CORPORATE ANALYSIS OF GERMANY PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY

1.1. Key Facts
1.2. Industry Volume
1.3. Industry Dynamics

2. GERMANY PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY COMPARATIVE ANALYSIS

2.1. Stock Analysis
2.2. Current Market State
2.3. Comparative Financial Analysis
  2.3.1. Profitability Analysis
  2.3.2. Margin Analysis
  2.3.3. Assets Turnover Analysis
  2.3.4. Credit Ratios
  2.3.5. Long-Term Solvency Analysis
  2.3.6. Growth Over Prior Year Trends

3. GERMANY PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY RANKINGS

3.1. Company Rankings by Size
3.2. Company Rankings by Value
3.3. Company Rankings by Profit Margins
3.4. Company Rankings by Growth History

4. GERMANY PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY NEWS

4.1. News & PR Activity Analysis
4.2. Germany Pharmaceuticals and Biotechnology Industry Significant Developments
4.3. Marketing News
4.4. Corporate Events

5. INDUSTRY EXPERTS FORECAST AND OPINIONS

APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

Table 1. The list of Companies Included in the Research
Table 2. Germany Pharmaceuticals and Biotechnology Industry Snapshot
Table 3. Germany Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income, 2011-2014
Table 4. Germany Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income
Table 5. Germany Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %
Table 6. Germany Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %
Table 7. Germany Pharmaceuticals and Biotechnology Industry Companies Stock Performance
Table 8. Companies Market Shares in 2011-2014, %
Table 9. Germany Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios
Table 10. Germany Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios
Table 11. Germany Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios
Table 12. Germany Pharmaceuticals and Biotechnology Industry Companies Credit Ratios
Table 13. Germany Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios
Table 14. Germany Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios
Table 15. Germany Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization
Table 16. Germany Pharmaceuticals and Biotechnology Industry Leaders by Revenues
Table 17. Germany Pharmaceuticals and Biotechnology Industry Leaders by Net Income
Table 18. Germany Pharmaceuticals and Biotechnology Industry Leaders by Employees
Table 19. Germany Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings
Table 20. Germany Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales
Table 21. Germany Pharmaceuticals and Biotechnology Industry Leaders by Price to Book
Table 22. Germany Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow
Table 23. Germany Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin
Table 24. Germany Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin
Table 25. Germany Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets
Table 26. Germany Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share
Table 27. Germany Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate


LIST OF FIGURES

Figure 1. Germany Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Industry Concentration in 2014, %
Figure 3. Germany Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends
Figure 4. Germany Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends
Figure 5. Germany Pharmaceuticals and Biotechnology Industry 1-year Stock Chart
Figure 6. Germany Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart
Figure 7. Germany Pharmaceuticals and Biotechnology Industry Structure by Companies, %
Figure 8. Growth-Share Matrix: Companies Strategic Position in Germany Pharmaceuticals and Biotechnology Industry (Recent Year Trends)
Figure 9. Growth-Share Matrix: Companies Strategic Position in Germany Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)
Figure 10. Return on Assets Chart by Companies in 2011-2014
Figure 11. Return on Equity Chart by Companies in 2011-2014
Figure 12. Profitability Peer Analysis
Figure 13. Profit Margin Chart by Companies in 2011-2014
Figure 14. Operating Margin Chart by Companies in 2011-2014
Figure 15. Margin Peer Analysis
Figure 16. Assets Turnover Peer Analysis
Figure 17. Current Ratio Chart by Companies in 2011-2014
Figure 18. Growth Over Prior Year Peer Analysis
Figure 19. Germany Pharmaceuticals and Biotechnology Industry Article Density Chart


THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:

Agennix AGAnalytik Jena AGBayer AG
Biofrontera AGBiotest AGCodon AG
Curasan AGCytoTools AGEpigenomics AG
Evotec AGGENEART AGGerresheimer AG
Girindus AGMediGene AGMerck KGaA
Mologen Holding AGMorphosys AGNovember AG
Paion AGSangui Biotech International Inc.Stada-Arzneimittel AG
Sygnis Pharma AGWilex AG4SC AG

The above Industry Comparative Analysis is a half-ready report.
It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. Business Analytic Center (BAC) has information for more than 40,000 different companies available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.

Skip to top


Ask Your Question

Germany Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: